The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9303033, A19, Table 33A, Compound 124 ID: ALA3968136
Chembl Id: CHEMBL3968136
PubChem CID: 137304476
Max Phase: Preclinical
Molecular Formula: C21H23N9O2
Molecular Weight: 433.48
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)c1ccccc1CNc1nc(NC2CC2)n2ncc(/C=C3\NC(=O)NC3=O)c2n1
Standard InChI: InChI=1S/C21H23N9O2/c1-29(2)16-6-4-3-5-12(16)10-22-19-26-17-13(9-15-18(31)27-21(32)25-15)11-23-30(17)20(28-19)24-14-7-8-14/h3-6,9,11,14H,7-8,10H2,1-2H3,(H2,22,24,26,28)(H2,25,27,31,32)/b15-9-
Standard InChI Key: NZZJCKSQVSIHFI-DHDCSXOGSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 433.48Molecular Weight (Monoisotopic): 433.1975AlogP: 1.56#Rotatable Bonds: 7Polar Surface Area: 128.58Molecular Species: NEUTRALHBA: 9HBD: 4#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1CX Acidic pKa: 7.24CX Basic pKa: 4.22CX LogP: 1.28CX LogD: 0.90Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.33Np Likeness Score: -1.17
References 1. (2016) Pyrazolopyrimidines and related heterocycles as CK2 inhibitors,